The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Roles of Sclerostin in Immune System and the Applications of Aptamers in Immune-Related Research
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-02-25
DOI
10.3389/fimmu.2021.602330
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atomistic probing of aptameric binding of CD19 outer membrane domain reveals an “aptamer walking” mechanism
- (2020) Michael K. Danquah et al. BIOTECHNOLOGY PROGRESS
- The Effects of Sclerostin on the Immune System
- (2020) Cristine Donham et al. Current Osteoporosis Reports
- Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System
- (2020) Christian Guder et al. Frontiers in Immunology
- Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies
- (2020) Estefanía Sicco et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
- (2020) Shuaijian Ni et al. ACS Applied Materials & Interfaces
- Aptamers as quality control tool for production, storage and biosimilarity of the anti-CD20 biopharmaceutical rituximab
- (2019) Sabrina Wildner et al. Scientific Reports
- Regulatory effect of Act1 on the BAFF pathway in B‑cell malignancy
- (2019) Xiao‑Jun Ge et al. Oncology Letters
- Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics
- (2019) Haseeb et al. Cells
- Wnt Signalling in Acute Myeloid Leukaemia
- (2019) Alicja M. Gruszka et al. Cells
- Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells
- (2019) Qingshan Pan et al. ACS Applied Materials & Interfaces
- An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
- (2019) Silvia Catuogno et al. Molecular Therapy-Nucleic Acids
- Selection of PD1/PD-L1 X-Aptamers
- (2018) Hongyu Wang et al. BIOCHIMIE
- Signalling for B cell survival
- (2018) Edina Schweighoffer et al. CURRENT OPINION IN CELL BIOLOGY
- Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
- (2018) Michael R McClung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development
- (2018) Cristal S Yee et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Selection and Characterization of Single-Stranded DNA Aptamers Binding Human B-Cell Surface Protein CD20 by Cell-SELEX
- (2018) Mansoureh Haghighi et al. MOLECULES
- Diffuse large B-cell lymphoma
- (2018) Shaoying Li et al. PATHOLOGY
- Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
- (2018) Yan Hu et al. Oncotarget
- Vhl deficiency in osteocytes produces high bone mass and hematopoietic defects
- (2018) Gabriela G. Loots et al. BONE
- SOST Gene Inhibits Osteogenesis from Adipose-Derived Mesenchymal Stem Cells by Inducing Th17 Cell Differentiation
- (2018) Li You et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Aptamer Based Targeted Drug Delivery Systems: Current Potential and Challenges
- (2018) Fen He et al. CURRENT MEDICINAL CHEMISTRY
- Targeting nucleolin for better survival in diffuse large B-cell lymphoma
- (2017) N Jain et al. LEUKEMIA
- Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth
- (2017) J Delgado-Calle et al. LEUKEMIA
- Deacetylase activity of histone deacetylase 3 is required for productiveVDJrecombination and B-cell development
- (2017) Kristy R. Stengel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aptamer Internalization via Endocytosis Inducing S-Phase Arrest and Priming Maver-1 Lymphoma Cells for Cytarabine Chemotherapy
- (2017) Huan Li et al. Theranostics
- Aptamers for CD Antigens: From Cell Profiling to Activity Modulation
- (2017) Amin Nozari et al. Molecular Therapy-Nucleic Acids
- Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights
- (2016) Smriti Murali Krishna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma
- (2016) J. Delgado-Calle et al. CANCER RESEARCH
- Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
- (2016) Homare Eda et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Current approaches in SELEX: An update to aptamer selection technology
- (2015) Mariia Darmostuk et al. BIOTECHNOLOGY ADVANCES
- Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma
- (2015) Felix Oden et al. Molecular Oncology
- Loss of sclerostin promotes osteoarthritis in mice via β-catenin-dependent and -independent Wnt pathways
- (2015) Wafa Bouaziz et al. ARTHRITIS RESEARCH & THERAPY
- Mucosal Immunity and B Cells in Teleosts: Effect of Vaccination and Stress
- (2015) David Parra et al. Frontiers in Immunology
- New insights into the location and form of sclerostin
- (2014) Paula Hernandez et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
- (2014) D. Hoelzer et al. BLOOD
- The DAN family: Modulators of TGF-β signaling and beyond
- (2014) Kristof Nolan et al. PROTEIN SCIENCE
- An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity
- (2014) U Krause et al. Cell Death & Disease
- Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
- (2013) J. F. Wise et al. BLOOD
- Aptamers from Cell-Based Selection for Bioanalytical Applications
- (2013) Weihong Tan et al. CHEMICAL REVIEWS
- Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches
- (2013) Lei Ding et al. NATURE
- Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
- (2013) Maarten van Dinther et al. PLoS One
- Nucleolin mediates nucleosome disruption critical for DNA double-strand break repair
- (2013) M. Goldstein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt/β-Catenin Signaling and Disease
- (2012) Hans Clevers et al. CELL
- Dickkopf-1 (DKK1) promotes invasion and metastasis of hepatocellular carcinoma
- (2012) Yi-Ming Tao et al. DIGESTIVE AND LIVER DISEASE
- Sclerostin: A new mediator of crosstalk between the skeletal and immune systems
- (2012) Mark C Horowitz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Absence of sclerostin adversely affects B-cell survival
- (2012) Corey J Cain et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The -Catenin Destruction Complex
- (2012) J. L. Stamos et al. Cold Spring Harbor Perspectives in Biology
- Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion
- (2011) Shizhuo Wang et al. CLINICAL & EXPERIMENTAL METASTASIS
- Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells
- (2011) Masato Tamura et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The immune system and bone
- (2010) Roberto Pacifici ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome
- (2010) T. Prebet et al. BLOOD
- How B cells influence bone biology in health and disease
- (2010) Mark C. Horowitz et al. BONE
- Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
- (2010) Carola Krause et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia decreases sclerostin expression and increases Wnt signaling in osteoblasts
- (2010) Damian C. Genetos et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Multiple myeloma
- (2009) Marc S Raab et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started